This increases its pro-inflammatory character and interferes with the regeneration capacity of damaged endothelium, which may underlie the association of ApoC3 guanidinylation with an increased progression of CKD as well as increased risk of cardiovascular events in CKD patients [22]. This evidence concerns the gene APOC3 and chronic kidney disease.